Princess Margaret signs MOU with Tata Memorial to pool cancer knowledge and expertise

NewsGuard 100/100 Score

Two world-renowned cancer centres today announced they will work together to further a shared vision of advancing innovation and delivery of best practices in all aspects of cancer care, research and education.

The two institutions - Canada's Princess Margaret Cancer Centre, University Health Network, Toronto and India's Tata Memorial Centre, Mumbai - signed a Memorandum of Understanding (MOU) here establishing the broad principles and framework to pool their internationally acclaimed cancer knowledge and expertise.

Signing on behalf of the Princess Margaret, Medical Director Dr. Mary Gospodarowicz said: "Cancer knows no borders and as pioneers in cancer care in our respective countries, we are a great match to collaborate on many fronts.

"Our shared vision is to create opportunities for joint ventures that will ultimately benefit cancer patients worldwide."

Signing on behalf of Tata Memorial Centre, Director Dr. Rajendra Badwe said: ""The meeting point of our two cultures, India and Canada, will be a melting pot for novelty in oncology."

Under terms of the MOU, the cancer centres will exchange information about patient care and clinical research, education and training.

They will also encourage academic collaborations, promote faculty exchanges and facilitate visits among students and trainees.

Other areas of mutual interest include advancing delivery of personalized cancer medicine and e-health initiatives.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery